Bicara Therapeutics Inc. (BCAX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.62
Day's range
$19.75

Bicara Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 7.26 M $144.32 M   4.31% 13.27%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 6.61 M $131.39 M   104.10% 12.08%
SIREN, L.L.C. 05/14/2026 5.80 M $115.42 M   11.23% 10.61%
VESTAL POINT CAPITAL, LP 05/15/2026 5.43 M $107.90 M   51.75% 9.92%
DEEP TRACK CAPITAL, LP 05/15/2026 4.06 M $80.80 M   55.41% 7.43%
JANUS HENDERSON GROUP PLC 05/18/2026 3.34 M $66.35 M   26.19% 6.11%
RED TREE MANAGEMENT, LLC 04/22/2026 3.17 M $63.06 M   0.00% 5.80%
TPG GP A, LLC 05/15/2026 3.01 M $59.88 M   0.00% 5.51%
BLACKROCK, INC. 05/13/2026 2.84 M $56.56 M   12.47% 5.20%
OMEGA FUND MANAGEMENT, LLC 05/15/2026 2.39 M $47.58 M   8.50% 4.38%
05/14/2026 2.39 M $46.69 M   89.06% 4.37%
FMR LLC 05/15/2026 2.10 M $41.79 M   -37.23% 3.84%
05/15/2026 1.77 M $35.29 M   100.00% 3.24%
CITADEL ADVISORS LLC 05/15/2026 1.66 M $33.00 M   114.87% 3.03%
FRANKLIN RESOURCES INC 05/13/2026 1.62 M $32.25 M   0.10% 2.97%
STATE STREET CORP 05/15/2026 1.42 M $28.23 M   -13.95% 2.60%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.38 M $27.37 M   -11.76% 2.52%
05/14/2026 1.26 M $25.06 M   100.00% 2.30%
HEALTHINVEST PARTNERS AB 05/11/2026 1.17 M $2.32 M   950.29% 2.14%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 830.91 K $16.53 M   2.40% 1.52%
FIL LTD 05/15/2026 679.90 K $13.52 M   -10.36% 1.24%
ORBIMED ADVISORS LLC 05/15/2026 667.30 K $13.27 M   219.13% 1.22%
ACORN CAPITAL ADVISORS, LLC 05/15/2026 643.38 K $12.80 M   0.00% 1.18%
AISLING CAPITAL MANAGEMENT LP 05/05/2026 568.92 K $11.32 M   0.00% 1.04%
GOLDMAN SACHS GROUP INC 05/15/2026 558.96 K $11.12 M   1.20% 1.02%
PALO ALTO INVESTORS LP 05/15/2026 550.41 K $10.95 M   84.35% 1.01%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 489.10 K $9.73 M   13.98% 0.89%
NAN FUNG TRINITY (HK) LTD 05/05/2026 427.89 K $8.51 M   14.90% 0.78%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 421.73 K $8.39 M   61.22% 0.77%
MORGAN STANLEY 05/15/2026 421.22 K $8.38 M   284.83% 0.77%
ENSIGN PEAK ADVISORS, INC 05/13/2026 401.44 K $7.98 M   0.00% 0.73%
ALGERT GLOBAL LLC 05/14/2026 330.83 K $6.58 M   3.95% 0.61%
BANK OF AMERICA CORP /DE/ 05/18/2026 327.99 K $6.52 M   -2.29% 0.60%
05/08/2026 290.94 K $5.79 M   100.00% 0.53%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 289.22 K $5.75 M   -3.19% 0.53%
D. E. SHAW & CO., INC. 05/15/2026 276.94 K $5.51 M   102.86% 0.51%
TD ASSET MANAGEMENT INC 05/11/2026 269.72 K $5.36 M   10.26% 0.49%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 263.99 K $5.25 M   -3.00% 0.48%
NORTHERN TRUST CORP 05/14/2026 255.57 K $5.08 M   7.79% 0.47%
CANDRIAM S.C.A. 04/30/2026 238.82 K $4.75 M   100.00% 0.44%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 233.70 K $4.65 M   55.80% 0.43%
WOODLINE PARTNERS LP 05/15/2026 232.69 K $4.63 M   0.00% 0.43%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 216.75 K $4.31 M   100.00% 0.40%
UBS GROUP AG 05/05/2026 179.49 K $3.57 M   -6.61% 0.33%
JPMORGAN CHASE & CO 05/13/2026 177.41 K $3.38 M   953.05% 0.32%
MILLENNIUM MANAGEMENT LLC 05/15/2026 156.70 K $3.12 M   -63.95% 0.29%
DEUTSCHE BANK AG\ 05/06/2026 131.66 K $2.62 M   2.36% 0.24%
NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD 05/12/2026 113.78 K $2.26 M   0.00% 0.21%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 109.26 K $2.17 M   166.92% 0.20%
WALLEYE CAPITAL LLC 05/13/2026 108.01 K $2.15 M   100.00% 0.20%

Bicara Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 169 institutional investors and hedge funds held shares of Bicara Therapeutics Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 7.26 M

T. Rowe Price Investment Management, Inc.: 6.61 M

Siren, L.L.C.: 5.8 M

Vestal Point Capital, LP: 5.43 M

Deep Track Capital, LP: 4.06 M

JANUS HENDERSON GROUP PLC: 3.34 M

130.33% of Bicara Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 67.92 M shares in the last 24 months. This purchase volume represents approximately $1.34 B in transactions.